Alaunos Therapeutics, Inc. - Common Stock TCRT 深 滬
已收盤 10-31 16:00:00 美东时间
2.72
+0.040
+1.49%
華盛通- 最 高2.8183
- 今 開2.71
- 成交量 1.63万股
- 最 低 2.652
- 昨 收 2.68
- 總市值 599.95万
- 52周最高 6.20
- 市盈率 靜 --
- 換手率 0.74%
- 52周最低 1.3137
- 委 比 80.00%
- 總股本 220.57万
- 歷史最高 2239.50
- 量 比 0.50
- 振 幅 6.21%
- 歷史最低 1.3137
- 每 手 1
- 風險率 0.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares rose 113.4% to $3.99 during T...
10-09 20:07
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Shares of Richardson Electronics, Ltd. (NASDAQ:RELL) rose sharply in pre-market...
10-09 17:12
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
09-03 18:21
Alaunos Therapeutics Regains Nasdaq Compliance
Alaunos Therapeutics ( ($TCRT) ) has shared an update. On August 19, 2025, Alau...
08-21 05:50
Alaunos Therapeutics Q2 EPS $(0.63) Up From $(0.71) YoY
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 percent increase over losses of $(0.71) per share from the same period last year.
08-15 04:44
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
Alaunos Therapeutics Inc (($TCRT)) announced an update on their ongoing clinica...
08-13 00:13
Alaunos Therapeutics Announces Departure of Melinda Lackey
Alaunos Therapeutics ( ($TCRT) ) has provided an announcement. On July 16, 2025...
07-23 05:20
Alaunos Therapeutics Raises $850,000 in Private Offering
An announcement from Alaunos Therapeutics ( ($TCRT) ) is now available. On June...
06-26 21:18
Alaunos Therapeutics stock slides on $2M equity offering
Alaunos Therapeutics (NASDAQ:TCRT) shares fell over 14% premarket on Monday after the company launched an equity offering to raise around $2M in proceeds. The offering comprises 610,399 shares of comm...
06-23 20:45
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
Alaunos Therapeutics has completed a registered direct offering of approximately 610,399 shares at $3.36 per share, raising around $2.0 million to support its obesity program and general corporate initiatives. The offering, conducted under a 2022 SEC-registered shelf, is set to close on June 24, 2025, subject to customary conditions.
06-23 12:00
